NEW YORK--(BUSINESS WIRE)--IRX Therapeutics, a privately-held company dedicated to the development and commercialization of novel drugs for the treatment of cancer and viral diseases, today announced that Jean Louis Lefebvre, M.D., ENT and Head and Neck Surgeon has joined its Medical Advisory Board.
